|
US4187852A
(en)
|
1976-07-09 |
1980-02-12 |
The University Of Alabama |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
|
US4132746A
(en)
|
1976-07-09 |
1979-01-02 |
University Of Alabama, Birmingham Medical & Education Foundation |
Synthetic elastomeric insoluble cross-linked polypentapeptide
|
|
DE2923787A1
(de)
*
|
1979-06-12 |
1980-12-18 |
Max Planck Gesellschaft |
Verfahren zur selektiven bildung von disulfidbruecken in polypeptiden und die dabei erhaltenen produkte als wirkstoffe enthaltende arzneimittel
|
|
US4500700A
(en)
|
1981-10-02 |
1985-02-19 |
The Board Of Trustees Of The University Of Alabama For The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypentapeptide having an amino acid of opposite chirality in position three
|
|
US4474851A
(en)
*
|
1981-10-02 |
1984-10-02 |
The University Of Alabama In Birmingham |
Elastomeric composite material comprising a polypeptide
|
|
US4589882A
(en)
|
1983-09-19 |
1986-05-20 |
Urry Dan W |
Enzymatically crosslinked bioelastomers
|
|
US4752638A
(en)
|
1983-11-10 |
1988-06-21 |
Genetic Systems Corporation |
Synthesis and use of polymers containing integral binding-pair members
|
|
US4749647A
(en)
|
1984-06-22 |
1988-06-07 |
Genetic Systems Corporation |
Polymerization-induced separation assay using recognition pairs
|
|
US4605641A
(en)
|
1984-10-09 |
1986-08-12 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
|
US4780409A
(en)
|
1985-05-02 |
1988-10-25 |
Genetic Systems Corporation |
Thermally induced phase separation immunoassay
|
|
US4783523A
(en)
*
|
1986-08-27 |
1988-11-08 |
Urry Dan W |
Temperature correlated force and structure development of elastin polytetrapeptides and polypentapeptides
|
|
US4870055A
(en)
*
|
1986-04-17 |
1989-09-26 |
University Of Alabama At Birmingham |
Segmented polypeptide bioelastomers to modulate elastic modulus
|
|
US5614492A
(en)
|
1986-05-05 |
1997-03-25 |
The General Hospital Corporation |
Insulinotropic hormone GLP-1 (7-36) and uses thereof
|
|
US7138486B2
(en)
*
|
1986-05-05 |
2006-11-21 |
The General Hospital Corporation |
Insulinotropic hormone derivatives and uses thereof
|
|
US4898926A
(en)
*
|
1987-06-15 |
1990-02-06 |
The University Of Alabama At Birmingham/Research Foundation |
Bioelastomer containing tetra/penta-peptide units
|
|
US6184348B1
(en)
*
|
1986-11-04 |
2001-02-06 |
Protein Polymer Technologies |
Functional recombinantly prepared synthetic protein polymer
|
|
US6018030A
(en)
*
|
1986-11-04 |
2000-01-25 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US5770697A
(en)
*
|
1986-11-04 |
1998-06-23 |
Protein Polymer Technologies, Inc. |
Peptides comprising repetitive units of amino acids and DNA sequences encoding the same
|
|
US5773249A
(en)
*
|
1986-11-04 |
1998-06-30 |
Protein Polymer Technologies, Inc. |
High molecular weight collagen-like protein polymers
|
|
US5830713A
(en)
*
|
1986-11-04 |
1998-11-03 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US5641648A
(en)
*
|
1986-11-04 |
1997-06-24 |
Protein Polymer Technologies, Inc. |
Methods for preparing synthetic repetitive DNA
|
|
US5496712A
(en)
*
|
1990-11-06 |
1996-03-05 |
Protein Polymer |
High molecular weight collagen-like protein polymers
|
|
US5514581A
(en)
*
|
1986-11-04 |
1996-05-07 |
Protein Polymer Technologies, Inc. |
Functional recombinantly prepared synthetic protein polymer
|
|
US5243038A
(en)
*
|
1986-11-04 |
1993-09-07 |
Protein Polymer Technologies, Inc. |
Construction of synthetic DNA and its use in large polypeptide synthesis
|
|
US5606019A
(en)
*
|
1987-10-29 |
1997-02-25 |
Protien Polymer Technologies, Inc. |
Synthetic protein as implantables
|
|
IL87055A
(en)
|
1988-07-08 |
1994-06-24 |
Illana Gozes |
Conjugates of vasoactive intestinal peptide (vip) and of fragments thereof and pharmaceutical compositions comprising them
|
|
US5137711A
(en)
|
1988-07-19 |
1992-08-11 |
Mallickrodt Medical, Inc. |
Paramagnetic dtpa and edta alkoxyalkylamide complexes as mri agents
|
|
US5766883A
(en)
|
1989-04-29 |
1998-06-16 |
Delta Biotechnology Limited |
Polypeptides
|
|
US5143854A
(en)
|
1989-06-07 |
1992-09-01 |
Affymax Technologies N.V. |
Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
|
|
US5234907A
(en)
|
1989-06-30 |
1993-08-10 |
Hoffmann-La Roche Inc. |
Synthetic vasoactive intestinal peptide analogs
|
|
US5236904A
(en)
|
1989-09-18 |
1993-08-17 |
Senetek, Plc |
Erection-inducing methods and compositions
|
|
US5447912A
(en)
|
1989-09-18 |
1995-09-05 |
Senetek, Plc |
Erection-inducing methods and compositions
|
|
US5545618A
(en)
|
1990-01-24 |
1996-08-13 |
Buckley; Douglas I. |
GLP-1 analogs useful for diabetes treatment
|
|
ATE114458T1
(de)
|
1990-03-27 |
1994-12-15 |
Bioelastics Res Ltd |
Bioelastomeres arzneimittelabgabesystem.
|
|
JPH07108232B2
(ja)
|
1990-10-09 |
1995-11-22 |
エム・ディ・リサーチ株式会社 |
ペプチド又は蛋白質の製造方法
|
|
US5235041A
(en)
*
|
1990-12-28 |
1993-08-10 |
Protein Polymer Technologies, Inc. |
Purification of structurally ordered recombinant protein polymers
|
|
US5646016A
(en)
*
|
1991-02-06 |
1997-07-08 |
Genetics Institute, Inc. |
Peptide and protein fusions to thioredoxin, thioredoxin-like molecules, and modified thioredoxin-like molecules
|
|
US5595732A
(en)
|
1991-03-25 |
1997-01-21 |
Hoffmann-La Roche Inc. |
Polyethylene-protein conjugates
|
|
US5393602A
(en)
|
1991-04-19 |
1995-02-28 |
Bioelastics Research Ltd. |
Superabsorbent materials and uses thereof
|
|
US5958881A
(en)
|
1991-04-25 |
1999-09-28 |
Korman; Louis Y. |
Composition containing VIP for injection and a method of enhancing visualization of tissues during medical procedures
|
|
IL99924A
(en)
|
1991-10-31 |
1995-12-31 |
Yeda Res & Dev |
Derivatives of structurally modified vip and pharmaceutical compositions containing them
|
|
US5681816A
(en)
|
1992-04-24 |
1997-10-28 |
Korman; Louis Y. |
Method of inducing temporary paralysis of the gastrointestinal tract during medical procedure
|
|
BR9306551A
(pt)
|
1992-06-15 |
1998-09-15 |
Pfizer |
Derivados de peptídeo do tipo glucagona e de insulinotropina
|
|
US5288514A
(en)
|
1992-09-14 |
1994-02-22 |
The Regents Of The University Of California |
Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
|
|
US5972883A
(en)
|
1993-03-16 |
1999-10-26 |
Yeda Research And Development Co. Ltd. |
Method for the treatment of neurodegenerative diseases by administering VIP, an analogue, fragment or a conjugate thereof
|
|
DK38293D0
(da)
|
1993-03-31 |
1993-03-31 |
Novo Nordisk As |
Fremstilling af proteiner
|
|
US5545617A
(en)
|
1993-11-12 |
1996-08-13 |
The Schepens Eye Research Institute, Inc. |
Therapeutic regulation of abnormal conjunctival goblet cell mucous secretion
|
|
US5705483A
(en)
*
|
1993-12-09 |
1998-01-06 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
EP0658568A1
(en)
|
1993-12-09 |
1995-06-21 |
Eli Lilly And Company |
Glucagon-like insulinotropic peptides, compositions and methods
|
|
US5900405A
(en)
*
|
1994-01-24 |
1999-05-04 |
Bioelastics Research, Ltd. |
Polymers responsive to electrical energy
|
|
CA2187322A1
(en)
|
1994-04-07 |
1995-10-19 |
Israel Rubinstein |
Vasoactive intestinal polypeptide
|
|
US5527610A
(en)
*
|
1994-05-20 |
1996-06-18 |
The Uab Research Foundation |
Elastomeric polypeptide matrices for preventing adhesion of biological materials
|
|
WO1996005310A1
(en)
|
1994-08-09 |
1996-02-22 |
Regents Of The University Of Minnesota |
Dna encoding turkey hypothalamic vasoactive intestinal peptide
|
|
US5854387A
(en)
*
|
1995-04-14 |
1998-12-29 |
Bioelastics Research, Ltd. |
Simple method for the purification of a bioelastic polymer
|
|
US6004782A
(en)
*
|
1995-04-14 |
1999-12-21 |
Bioelastics Research Ltd. |
Hyperexpression of bioelastic polypeptides
|
|
US5972406A
(en)
*
|
1995-04-14 |
1999-10-26 |
Bioelastics Research Ltd. |
Bioelastomers suitable as food product additives
|
|
US5624711A
(en)
|
1995-04-27 |
1997-04-29 |
Affymax Technologies, N.V. |
Derivatization of solid supports and methods for oligomer synthesis
|
|
US6037321A
(en)
|
1995-05-03 |
2000-03-14 |
Biostar Inc. |
Fusion proteins comprising vasoactive intestinal peptide or PACAP
|
|
EP0851768B1
(en)
*
|
1995-09-01 |
2002-04-24 |
University of Washington |
Interactive molecular conjugates
|
|
JP3628333B2
(ja)
|
1995-09-21 |
2005-03-09 |
ジェネンテック インコーポレーテッド |
ヒト成長ホルモン変異体
|
|
US5702717A
(en)
*
|
1995-10-25 |
1997-12-30 |
Macromed, Inc. |
Thermosensitive biodegradable polymers based on poly(ether-ester)block copolymers
|
|
DE122004000004I1
(de)
|
1996-02-09 |
2004-08-12 |
Abott Biotechnology Ltd |
Humane Antikörper welche an Humanen TNFalpha binden.
|
|
US6063061A
(en)
|
1996-08-27 |
2000-05-16 |
Fusion Medical Technologies, Inc. |
Fragmented polymeric compositions and methods for their use
|
|
IL128332A0
(en)
|
1996-08-30 |
2000-01-31 |
Novo Nordisk As |
GLP-1 derivatives
|
|
US5816259A
(en)
|
1997-01-13 |
1998-10-06 |
Rose; Samuel |
Method for the diagnosis and treatment of cancer by the accumulation of radioactive precipitates in targeted cells
|
|
FI103540B
(fi)
|
1997-04-28 |
1999-07-15 |
Nokia Mobile Phones Ltd |
Menetelmä pakettikytkentäisen datan siirtoon matkapuhelinjärjestelmäss ä
|
|
GB9718463D0
(en)
|
1997-08-29 |
1997-11-05 |
Dynal As |
Biomolecules
|
|
US20020099003A1
(en)
|
1997-10-28 |
2002-07-25 |
Wilson Leland F. |
Treatment of female sexual dysfunction with vasoactive agents, particularly vasoactive intestinal polypeptide and agonists thereof
|
|
KR100627590B1
(ko)
|
1998-01-30 |
2006-09-25 |
다이이치 아스비오파마 가부시키가이샤 |
보조 펩타이드를 사용하는 펩타이드의 제조방법
|
|
US6703359B1
(en)
*
|
1998-02-13 |
2004-03-09 |
Amylin Pharmaceuticals, Inc. |
Inotropic and diuretic effects of exendin and GLP-1
|
|
AU2798599A
(en)
*
|
1998-02-27 |
1999-09-15 |
Bioelastics Research Ltd. |
Injectable implants for tissue augmentation and restoration
|
|
US6998387B1
(en)
*
|
1998-03-19 |
2006-02-14 |
Amylin Pharmaceuticals, Inc. |
Human appetite control by glucagon-like peptide receptor binding compounds
|
|
FR2776520B1
(fr)
|
1998-03-25 |
2000-05-05 |
Sod Conseils Rech Applic |
Nouvelles compositions pharmaceutiques destinees a la liberation prolongee de peptides et leur procede de preparation
|
|
US6153655A
(en)
|
1998-04-17 |
2000-11-28 |
Enzon, Inc. |
Terminally-branched polymeric linkers and polymeric conjugates containing the same
|
|
ES2138561B1
(es)
|
1998-04-17 |
2000-07-01 |
Univ Madrid Complutense |
Uso de los peptidos vip y pacap en el tratamiento del shock endotoxico en mamiferos.
|
|
US20020151458A1
(en)
|
1998-04-17 |
2002-10-17 |
Perez Gomariz Rosa Maria |
Method for treating and preventing septic shock with VPAC1R, VPAC2R and PAC1R agonists
|
|
US6200598B1
(en)
*
|
1998-06-18 |
2001-03-13 |
Duke University |
Temperature-sensitive liposomal formulation
|
|
US6451986B1
(en)
|
1998-06-22 |
2002-09-17 |
Immunex Corporation |
Site specific protein modification
|
|
US6541033B1
(en)
|
1998-06-30 |
2003-04-01 |
Amgen Inc. |
Thermosensitive biodegradable hydrogels for sustained delivery of leptin
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
ATE445006T1
(de)
|
1998-08-10 |
2009-10-15 |
Us Gov Health & Human Serv |
Differenzierung von nicht-insulin in insulin- produzierende zellen durch glp-1 und exendin-4 und dessen verwendung
|
|
CN1495198A
(zh)
|
1998-12-07 |
2004-05-12 |
�о���Ӧ�ÿ�ѧЭ��ɷ�����˾ |
胰高血糖素样肽-1的类似物
|
|
US6630438B1
(en)
|
1999-03-12 |
2003-10-07 |
The Procter & Gamble Company |
Perfumed detergent tablet
|
|
WO2000056774A1
(en)
*
|
1999-03-19 |
2000-09-28 |
Duke University |
Methods of using bioelastomers
|
|
US20090175821A1
(en)
|
1999-05-17 |
2009-07-09 |
Bridon Dominique P |
Modified therapeutic peptides with extended half-lives in vivo
|
|
EP1180121B9
(en)
|
1999-05-17 |
2004-09-08 |
Conjuchem, Inc. |
Long lasting insulinotropic peptides
|
|
CZ299516B6
(cs)
|
1999-07-02 |
2008-08-20 |
F. Hoffmann-La Roche Ag |
Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
|
|
US6528486B1
(en)
*
|
1999-07-12 |
2003-03-04 |
Zealand Pharma A/S |
Peptide agonists of GLP-1 activity
|
|
EP1076066A1
(en)
|
1999-07-12 |
2001-02-14 |
Zealand Pharmaceuticals A/S |
Peptides for lowering blood glucose levels
|
|
JP2004500906A
(ja)
|
1999-11-12 |
2004-01-15 |
ルーベン， レオ |
電気的調節および化学的調節のための心臓デバイス、ならびに心肺障害の処置のための血管作用性腸ペプチド
|
|
US6235264B1
(en)
|
1999-12-01 |
2001-05-22 |
General Electric Company |
Medical imaging method for characterizing tumor angiogenesis using polymeric contrast agents
|
|
US6593394B1
(en)
|
2000-01-03 |
2003-07-15 |
Prosperous Kingdom Limited |
Bioactive and osteoporotic bone cement
|
|
US7833992B2
(en)
|
2001-05-18 |
2010-11-16 |
Merck Sharpe & Dohme |
Conjugates and compositions for cellular delivery
|
|
EP1257576B1
(en)
|
2000-02-18 |
2004-09-15 |
Dabur Research Foundation |
Vasoactive intestinal peptide analogs
|
|
US20050255554A1
(en)
|
2000-03-20 |
2005-11-17 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
|
US6852834B2
(en)
*
|
2000-03-20 |
2005-02-08 |
Ashutosh Chilkoti |
Fusion peptides isolatable by phase transition
|
|
JP2003530838A
(ja)
|
2000-04-12 |
2003-10-21 |
ヒューマン ゲノム サイエンシズ インコーポレイテッド |
アルブミン融合タンパク質
|
|
US6905683B2
(en)
|
2000-05-03 |
2005-06-14 |
Novo Nordisk Healthcare A/G |
Human coagulation factor VII variants
|
|
AU6479101A
(en)
*
|
2000-06-16 |
2002-01-02 |
Lilly Co Eli |
Glucagon-like peptide-1 analogs
|
|
US20030211094A1
(en)
|
2001-06-26 |
2003-11-13 |
Nelsestuen Gary L. |
High molecular weight derivatives of vitamin k-dependent polypeptides
|
|
CZ2003611A3
(cs)
|
2000-09-13 |
2003-08-13 |
Novo Nordisk A/S |
Varianty lidského koagulačního faktoru VII
|
|
US20020142964A1
(en)
|
2000-11-02 |
2002-10-03 |
Nissen Torben Lauesgaard |
Single-chain polypeptides
|
|
AU2072002A
(en)
|
2000-11-28 |
2002-06-11 |
Mondobiotech Sa |
Compounds with the biological activity of vasoactive intestinal peptide for the treatment of pulmonary and arteriolar hypertension
|
|
UA93662C2
(uk)
*
|
2000-12-07 |
2011-03-10 |
Эли Лилли Энд Компани |
Гетерологічний пептидильований глюкагон-подібний білок та його застосування для виготовлення лікарського засобу для лікування пацієнтів, що страждають на ожиріння або інсулінонезалежний цукровий діабет
|
|
EP1390061A2
(en)
*
|
2000-12-13 |
2004-02-25 |
Eli Lilly And Company |
Chronic treatment regimen using glucagon-like insulinotropic peptides
|
|
AU2002233089B2
(en)
*
|
2001-02-16 |
2005-12-22 |
Conjuchem Biotechnologies Inc. |
Long lasting glucagon-like peptide 2 (GLP-2) for the treatment of gastrointestinal diseases and disorders
|
|
CZ20032454A3
(en)
|
2001-03-22 |
2004-03-17 |
Novo Nordisk Health Care Ag |
Coagulation factor vii derivative
|
|
US7235638B2
(en)
|
2001-03-22 |
2007-06-26 |
Novo Nordisk Healthcare A/G |
Coagulation factor VII derivatives
|
|
AU2002308706A1
(en)
*
|
2001-06-01 |
2002-12-16 |
Eli Lilly And Company |
Glp-1 formulations with protracted time action
|
|
CA2458371A1
(en)
|
2001-08-23 |
2003-03-06 |
Eli Lilly And Company |
Glucagon-like peptide-1 analogs
|
|
WO2003020201A2
(en)
*
|
2001-08-28 |
2003-03-13 |
Eli Lilly And Company |
Pre-mixes of glp-1 and basal insulin
|
|
US7176278B2
(en)
|
2001-08-30 |
2007-02-13 |
Biorexis Technology, Inc. |
Modified transferrin fusion proteins
|
|
JP2005508360A
(ja)
*
|
2001-10-19 |
2005-03-31 |
イーライ・リリー・アンド・カンパニー |
Ｇｌｐ−１およびインスリンの二相混合物
|
|
WO2003039577A1
(en)
|
2001-11-06 |
2003-05-15 |
Senju Pharmaceutical Co., Ltd. |
Remedies for dry eye and diseases associated with dry eye
|
|
DE10155862A1
(de)
|
2001-11-14 |
2003-05-28 |
Ipk Inst Fuer Pflanzengenetik |
Produktion von rekombinanten Antikörpern mittels Fusion mit Elastin-ähnlichen Peptiden
|
|
ES2425738T3
(es)
|
2001-12-21 |
2013-10-17 |
Human Genome Sciences, Inc. |
Proteínas de fusión de la albúmina
|
|
US7553485B2
(en)
|
2002-01-18 |
2009-06-30 |
Pierre Fabre Medicament |
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses thereof
|
|
US20030199445A1
(en)
|
2002-02-07 |
2003-10-23 |
Knudsen Lotte Bjerre |
Use of GLP-1 compound for treatment of critically ill patients
|
|
WO2003099835A1
(en)
|
2002-05-21 |
2003-12-04 |
Emory University |
Multivalent polymers with chain-terminating binding groups
|
|
CA2488358A1
(en)
|
2002-06-10 |
2003-12-18 |
Mondobiotech Laboratories Anstalt |
Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis
|
|
EP1545595B1
(en)
|
2002-08-30 |
2010-07-07 |
Biorexis Pharmaceutical Corporation |
Modified transferrin fusion proteins comprising duplicate transferrin amino or carboxy terminal domains
|
|
EP1571155B1
(en)
|
2002-11-27 |
2011-08-24 |
Ils Inc. |
Peptides and medicinal compositions containing the same
|
|
US20050026826A1
(en)
*
|
2003-01-17 |
2005-02-03 |
Margarethe Hoenig |
Feline proinsulin, insulin and constituent peptides
|
|
JP4629046B2
(ja)
|
2003-05-14 |
2011-02-09 |
ダニスコ・ユーエス・インコーポレーテッド |
反復配列タンパク質ポリマー活性剤結合体、方法および使用
|
|
EP1633391B1
(en)
*
|
2003-06-03 |
2011-10-19 |
Novo Nordisk A/S |
Stabilized pharmaceutical peptide compositions
|
|
EA008831B1
(ru)
|
2003-06-12 |
2007-08-31 |
Эли Лилли Энд Компани |
Слитые белки аналогов glp-1
|
|
US20040266993A1
(en)
*
|
2003-06-30 |
2004-12-30 |
Evans Glen A. |
Non-immunoglobulin binding polypeptides
|
|
AU2004255379B2
(en)
|
2003-07-14 |
2007-08-16 |
Mondobiotech Ag |
Biologically active substance of a vasoactive intestinal peptide for treating interstitial lung infections
|
|
WO2005014030A1
(en)
|
2003-07-24 |
2005-02-17 |
Lutz-Henning Block |
Method for treating lung diseases associated with ventilation-perfusion mismatches
|
|
JP2007520531A
(ja)
|
2004-02-05 |
2007-07-26 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
外傷の治療のための、ＶＩＩａ因子の使用
|
|
US7928059B2
(en)
|
2004-02-24 |
2011-04-19 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for traumatic cartilage injury
|
|
US7776815B2
(en)
|
2004-02-24 |
2010-08-17 |
Wisconsin Alumni Research Foundation |
Use of neuropeptides for ligament healing
|
|
US20050203009A1
(en)
|
2004-03-12 |
2005-09-15 |
Bayer Pharmaceuticals Corporation |
VPAC1 selective antagonists and their pharmacological methods of use
|
|
AU2005231342A1
(en)
|
2004-03-29 |
2005-10-20 |
The Arizona Board Of Regents On Behalf Of The University Of Arizona |
Amphipathic glycopeptides
|
|
MXPA06014462A
(es)
|
2004-06-11 |
2007-05-23 |
Vectus Biosystems Ltd |
Composiciones y metodos para tratamiento de enfermedades cardiovasculares.
|
|
CA2575101A1
(en)
|
2004-06-12 |
2005-12-29 |
Bayer Pharmaceuticals Corporation |
Pegylation of vasoactive intestinal peptide (vip)/pituitary adenylate cyclase activating peptide (pacap) receptor 2 (vpac2) agonists and methods of use
|
|
WO2006001806A2
(en)
|
2004-06-15 |
2006-01-05 |
Duke University |
Method for non-invasive thermometry using elastin-like polypeptide conjugates
|
|
US7638299B2
(en)
*
|
2004-07-21 |
2009-12-29 |
Ambrx, Inc. |
Biosynthetic polypeptides utilizing non-naturally encoded amino acids
|
|
US20080085860A1
(en)
|
2004-08-18 |
2008-04-10 |
Eli Lilly And Company |
Selective Vpac2 Receptor Peptide Agonists
|
|
MX2007004116A
(es)
|
2004-10-08 |
2007-10-05 |
Forbes Medi Tech Res Inc |
Composiciones farmaceuticas de polipeptidos intestinales vasoactivos.
|
|
SE0402976L
(sv)
*
|
2004-12-03 |
2006-06-04 |
Mederio Ag |
Medicinsk produkt
|
|
CA2589118A1
(en)
|
2004-12-03 |
2006-06-08 |
Mederio Ag |
A medical product comprising a glucagon-like peptide medicament intended for pulmonary inhalation
|
|
US20080312156A1
(en)
|
2005-01-18 |
2008-12-18 |
Duke University |
In-Situ Crosslinkable Elastin-Like Polypeptides for Defect Filling in Cartilaginous Tissue Repair
|
|
US7723472B2
(en)
|
2005-02-28 |
2010-05-25 |
The Regents Of The University Of California |
Extracellular matrix binding chimeric proteins and methods of use thereof
|
|
WO2006110292A2
(en)
|
2005-03-25 |
2006-10-19 |
The Regents Of The University Of California |
Temperature-triggered immobilization and purification of antibodies
|
|
TW200722088A
(en)
|
2005-05-27 |
2007-06-16 |
Sankyo Co |
Diabetes remedy
|
|
US20070031342A1
(en)
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
|
EP3725299A1
(en)
*
|
2005-06-24 |
2020-10-21 |
Duke University |
A direct drug delivery system based on thermally responsive biopolymers
|
|
US20070041934A1
(en)
|
2005-08-12 |
2007-02-22 |
Regents Of The University Of Michigan |
Dendrimer based compositions and methods of using the same
|
|
US7542904B2
(en)
*
|
2005-08-19 |
2009-06-02 |
Cisco Technology, Inc. |
System and method for maintaining a speech-recognition grammar
|
|
PT1767545E
(pt)
*
|
2005-09-22 |
2010-02-05 |
Biocompatibles Uk Ltd |
Polipéptidos de fusão glp-1 (péptido 1 do tipo glucagom) com resistência aumentada à peptidase
|
|
AU2006306236B2
(en)
|
2005-10-26 |
2011-12-01 |
Eli Lilly And Company |
Selective VPAC2 receptor peptide agonists
|
|
DE602006012358D1
(de)
|
2005-11-18 |
2010-04-01 |
Dabur Pharma Ltd |
Zielgerichtete fusionsproteine für die krebstherapie
|
|
RU2466738C2
(ru)
|
2005-12-09 |
2012-11-20 |
Вектас Байосистемз Лимитед |
Фрагменты vip и способы их применения
|
|
US8334257B2
(en)
|
2005-12-20 |
2012-12-18 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US20130172274A1
(en)
|
2005-12-20 |
2013-07-04 |
Duke University |
Methods and compositions for delivering active agents with enhanced pharmacological properties
|
|
US8841255B2
(en)
|
2005-12-20 |
2014-09-23 |
Duke University |
Therapeutic agents comprising fusions of vasoactive intestinal peptide and elastic peptides
|
|
US7709227B2
(en)
|
2006-01-04 |
2010-05-04 |
Phasebio Pharmaceuticals, Inc. |
Multimeric ELP fusion constructs
|
|
WO2007100535A2
(en)
*
|
2006-02-22 |
2007-09-07 |
Merck & Co., Inc. |
Oxyntomodulin derivatives
|
|
EP2863222A1
(en)
|
2006-03-06 |
2015-04-22 |
Amunix Operating Inc. |
Unstructured recombinant polymers and uses thereof
|
|
ES2315081B1
(es)
|
2006-03-15 |
2009-12-30 |
Grup D'afectats D'esclerosi Multiple (Gaem) |
Nuevo uso del peptido intestinal vasoactivo (vip) y de las celulas aisladas estimuladas con dicho peptido.
|
|
US20100189643A1
(en)
|
2006-07-24 |
2010-07-29 |
Duke University |
Drug delivery with stimulus responsive biopolymers
|
|
EP2054437A2
(en)
|
2006-08-07 |
2009-05-06 |
Teva Biopharmaceuticals USA, Inc. |
Albumin-insulin fusion proteins
|
|
JP5290177B2
(ja)
*
|
2006-08-31 |
2013-09-18 |
セントカー・インコーポレーテツド |
Ｇｌｐ−２ミメティボディ、ポリペプチド、組成物、方法および用途
|
|
CN101578373A
(zh)
*
|
2006-09-06 |
2009-11-11 |
费斯生物制药公司 |
融合肽治疗组合物
|
|
ES2373824T3
(es)
|
2007-05-21 |
2012-02-09 |
Res International Sarl |
Péptidos con propiedades mejoradas que tienen la actividad biológica del péptido intestinal vasoactivo (piv) y su uso para el tratamiento de enfermedades pulmonares.
|
|
WO2008154234A2
(en)
|
2007-06-08 |
2008-12-18 |
Boehringer Ingelheim International Gmbh |
Extended release formulation of nevirapine
|
|
HRP20110368T1
(hr)
|
2007-06-21 |
2011-06-30 |
Technische Universitt Mnchen |
Biološki aktivni proteini s povećanom stabilnošću in vivo i/ili in vitro
|
|
CN103298935A
(zh)
*
|
2007-08-15 |
2013-09-11 |
阿穆尼克斯公司 |
用于改善生物活性多肽性能的组合物和方法
|
|
ES2672770T3
(es)
|
2007-09-05 |
2018-06-18 |
Novo Nordisk A/S |
Derivados del péptido-1 similar al glucagón y su uso farmacéutico
|
|
CN101918027A
(zh)
|
2007-11-02 |
2010-12-15 |
森托科尔奥索生物科技公司 |
半合成GLP-1肽-Fc融合构造、方法及其用途
|
|
WO2009067584A1
(en)
|
2007-11-20 |
2009-05-28 |
Duke University |
Methods and compositions for modulating drug-polymer architecture, pharmacokinetics and biodistribution
|
|
EP3412300A1
(en)
*
|
2008-06-27 |
2018-12-12 |
Duke University |
Therapeutic agents comprising elastin-like peptides
|
|
BRPI0914504B8
(pt)
|
2008-10-17 |
2021-05-25 |
Vectus Biosystems Pty Ltd |
uso de um peptídeo intestinal vasoativo (piv) ou um ou mais fragmentos funcionais do piv
|
|
US20110288001A1
(en)
|
2008-12-18 |
2011-11-24 |
Homayoun Sadeghi |
Biologically active proteins activatable by peptidase
|
|
US8703717B2
(en)
|
2009-02-03 |
2014-04-22 |
Amunix Operating Inc. |
Growth hormone polypeptides and methods of making and using same
|
|
WO2011020091A1
(en)
|
2009-08-14 |
2011-02-17 |
Phasebio Pharmaceuticals, Inc. |
Modified vasoactive intestinal peptides
|
|
TW201138808A
(en)
*
|
2010-05-03 |
2011-11-16 |
Bristol Myers Squibb Co |
Serum albumin binding molecules
|
|
EP2717902B1
(en)
|
2011-06-06 |
2018-01-24 |
Phasebio Pharmaceuticals, Inc. |
Use of modified vasoactive intestinal peptides in the treatment of hypertension
|
|
CN104023784B
(zh)
|
2011-08-24 |
2018-05-25 |
费斯生物制药公司 |
供持续释放的活性剂制剂
|
|
HK1202067A1
(en)
|
2011-11-28 |
2015-09-18 |
Phasebio Pharmaceuticals, Inc. |
Therapeutic agents comprising insulin amino acid sequences
|
|
US9605186B2
(en)
|
2012-09-19 |
2017-03-28 |
Exxonmobil Chemical Patents Inc. |
Adhesive compositions of ethylene-based and propylene-based polymers
|